Clinical Trial Update: Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reports on the efficacy and safety of the valsartan/amlodipine combination in adults with mild to moderate essential hypertension;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Valsartan/amlodipine (Valsartan/amlodipine)

Snippet

Sponsor: Novartis | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-05-24